The first large comprehensive private hospital in China to pass JCI 6th Edition accreditation, passing Grade 3 Class A comprehensive hospital accreditation in 2021.

Designated as a "Hangzhou International Hospital" in 2021, a provincial and municipal medical insurance designated unit, national cross-province medical settlement hospital.

Obtained qualifications for four major organ transplantations (liver, kidney, heart, and lung), and successfully performed four major organ transplantations, one of the few private hospitals in China simultaneously possessing four major organ transplantation qualifications.

Teaching hospital of Zhejiang University, affiliated hospital of Zhejiang Shuren University Shulan International Medical School, national standardized residency training base (internal medicine, surgery, general practice, radiology, etc.), national drug clinical trial institution.

Rated as "Zhejiang Provincial Top Ten Quality Private Hospitals" for four consecutive years, awarded "Hangzhou Advanced Collective in COVID-19 Response" in 2020, rated as "Top Ten Medical Humanities Brand Hospitals of the Year" in 2022.

Friendly cooperative relationships with UCLA, Harvard Massachusetts General Hospital, Princeton University, University of Hong Kong, Peking Union Medical College Hospital, Macau University of Science and Technology, etc., establishing Shulan International Organ Transplantation Center, Intestinal Fistula and Abdominal Infection Treatment Center, Remote Home Automated Peritoneal Dialysis Center, and other international medical centers. Core Departments and Leadership Advantages

Led by Academician Zheng Shusen, obtained qualifications for four major organ transplantations (liver, kidney, heart, and lung). Nationally leading and internationally advanced in critical complex liver transplantation, living donor liver transplantation, dual adult split liver transplantation, and desensitization treatment for presensitized kidney transplant recipients. Established the Shulan International Organ Transplantation Center.

Led by Academician Li Lanjuan, leading in severe infection, sepsis, viral hepatitis, and liver failure. Created the artificial liver support system treatment concept, with rich experience in perioperative infection management for liver transplantation.

Leading in end-stage kidney disease replacement therapy, living-related kidney transplantation, blood purification, and peritoneal dialysis. Established the Remote Home Automated Peritoneal Dialysis Center.

Leading in severe acute pancreatitis, severe abdominal infection, and ECMO support, equipped with ECMO and other advanced life support devices.

Established multidisciplinary comprehensive oncology treatment models, leading in solid tumor chemotherapy, targeted therapy, and immunotherapy.

Established in 2022, focusing on multimorbidity, chronic disease management, with physical examination report interpretation and diagnosis and treatment of undifferentiated diseases such as edema, weight loss, and fatigue as characteristics.

Integrating medical care, rehabilitation, and nursing, equipped with German MOTOM bedside intelligent rehabilitation training systems, American DJO dysphagia treatment devices, and other advanced equipment, conducting neurological rehabilitation, fracture rehabilitation, and critical care rehabilitation.

Conducting over 120 projects and techniques including eye, nose, and facial contouring, facial profile shaping, skin beauty injections, scar repair, breast shaping, and body contouring.